Yoram Drucker
Vermogen: 2 M $ op 31-05-2026
Vermogen: 2 M $ op 31-05-2026
Yoram Nathan Drucker was the founder of Pluri, Inc. (2001), Brainstorm Cell Therapeutics, Inc. (2004) as Chief Executive & Operating Officer, Secretary, Cell Source Ltd. (2011) as Chairman, Pluri Biotech Ltd. (2004) as Director, InnoCan Pharma Corp.
(2018) as Director & Vice President-Business Development, NurExone Biologic, Inc. (2011) as Chairman & Vice President-Strategic Development, Virucure Ltd. (2005) as Chief Executive Officer, and NurExone Biologic Ltd. (2020) as Director.
Current job includes Director at I.R-Med Ltd. Former jobs include Chief Executive Officer & Chairman at Rainbow Energy Ltd. (2009-2011), CEO, President, Secretary, Treasurer & Director at Revium Recovery, Inc., Independent Director at Cell Source, Inc. (2015-2019), Director & VP-Business Development at IR-Med, Inc. (2019-2024), and Vice President-Business Development at Millennium Electric T.O.U.
Ltd.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 27-11-2025 | 3.655.000 ( 3,97% ) | 2 M $ | 31-05-2026 | |
IR-MED INC 5,24% | 04-04-2025 | 4.050.000 ( 5,24% ) | 4 050 $ | 31-01-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| NUREXONE BIOLOGIC INC. | Oprichter | 27-06-2011 |
I.R-Med Ltd.
I.R-Med Ltd. Electronic Equipment/InstrumentsElectronic Technology Provides patented interface analysis of Infra-Red light | Directeur/Bestuurslid | - |
NurExone Biologic Ltd.
NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops an off the shelf, non-invasive and revolutionary treatment for the reduction in the harmful results of spinal cord injury | Oprichter | 01-05-2020 |
| Bedrijven | Functie | Einde |
|---|---|---|
| IR-MED INC. | Directeur/Bestuurslid | 27-03-2024 |
| INNOCAN PHARMA CORPORATION | Oprichter | 01-06-2023 |
| CELL SOURCE, INC. | Voorzitter | 19-08-2015 |
Cell Source Ltd.
Cell Source Ltd. BiotechnologyHealth Technology Develops cell therapy treatments | Algemeen Directeur | 01-10-2013 |
Rainbow Energy Ltd. | Algemeen Directeur | 01-09-2011 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 14 |
|---|---|
Brainstorm Cell Therapeutics, Inc.
Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
Pluri, Inc.
Pluri, Inc. BiotechnologyHealth Technology Develops placenta-based cell therapy products for the treatment of muscle trauma and hematological disorders, radiation damage and inflammation | Health Technology |
Cell Source, Inc.
Cell Source, Inc. BiotechnologyHealth Technology Develops cell therapy treatments | Health Technology |
Cell Source Ltd.
Cell Source Ltd. BiotechnologyHealth Technology Develops cell therapy treatments | Health Technology |
Revium Recovery, Inc.
Revium Recovery, Inc. Food DistributorsDistribution Services Distributes alcoholic and non-alcoholic beverages | Distribution Services |
Pluri Biotech Ltd.
Pluri Biotech Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services in the biotechnology field, especially in stem cell research | Commercial Services |
Millennium Electric T.O.U. Ltd.
Millennium Electric T.O.U. Ltd. Building ProductsProducer Manufacturing Provides solar solutions | Producer Manufacturing |
Rainbow Energy Ltd. | |
InnoCan Pharma Corp.
InnoCan Pharma Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
I.R-Med Ltd.
I.R-Med Ltd. Electronic Equipment/InstrumentsElectronic Technology Provides patented interface analysis of Infra-Red light | Electronic Technology |
Virucure Ltd. | Commercial Services |
IR-Med, Inc.
IR-Med, Inc. Medical SpecialtiesHealth Technology Develops non-invasive devices for detecting and measuring biomarkers and molecules in the blood and in human tissue | Health Technology |
NurExone Biologic Ltd.
NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops an off the shelf, non-invasive and revolutionary treatment for the reduction in the harmful results of spinal cord injury | Health Technology |
NurExone Biologic, Inc.
NurExone Biologic, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops an off the shelf, non-invasive and revolutionary treatment for the reduction in the harmful results of spinal cord injury | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau